News - Healthcare, Diabetes

Filter

Current filters:

HealthcareDiabetes

Popular Filters

Quebec first province to add Victoza to the drug benefit formulary

Quebec first province to add Victoza to the drug benefit formulary

04-06-2014

The Canadian subsidiary of Danish diabetes care giant Novo Nordisk says that the Quebec government has…

CanadaDiabetesFinancialHealthcareNovo NordiskPharmaceuticalVictoza

Ukraine MoH signs “understanding” with insulin producers

24-03-2014

On March 19, Oleg Musiy, the Minister of Health in Ukraine, signed the memorandum of understanding with…

DiabetesEastern EuropeHealthcarePharmaceuticalPricingUkraine

Latest Australian PBS Listings include medicines for children

Latest Australian PBS Listings include medicines for children

19-03-2014

Ten new medicines to treat a range of illnesses from rare forms of cancer to skin conditions will be…

Anti-Arthritics/RheumaticsAsia-PacificAustraliaDermatologicalsDiabetesGastro-intestinalsHealthcareOncologyPharmaceuticalPricing

Australian patients benefit from PBS changes; cancer research

27-02-2014

New medicines for glaucoma, diabetes and advanced soft tissue sarcoma have been approved for listing…

Asia-PacificAustraliaDiabetesFinancialHealthcareKombiglyzeOncologyPharmaceuticalResearchTrajentaVotrient

Novo Nordisk launches diabetes collaboration focused on integrated care with London partners

Novo Nordisk launches diabetes collaboration focused on integrated care with London partners

27-01-2014

A unique collaboration between leading London hospitals and Danish insulin giant Novo Nordisk (NOV: N)…

DiabetesHealthcareNovo NordiskPharmaceuticalUK

Pharma appeals to Ukraine Health Ministry on insulin supply problems

Pharma appeals to Ukraine Health Ministry on insulin supply problems

27-01-2014

The Association of Pharmaceutical Research and Development and the American Chamber of Commerce in Ukraine…

DiabetesEastern EuropeHealthcarePharmaceuticalPricingUkraine

Cardiovascular risk a concern when prescribing diabetes treatments, survey finds

06-11-2013

Boehringer Ingelheim and Eli Lilly (NYSE: LLY) revealed that 79% of nearly 800 physicians in four Asian…

Asia-PacificBoehringer IngelheimDiabetesEli LillyHealthcarePharmaceuticalResearch

$200+ billion annual opportunity in USA from using medicines more responsibly, IMS finds

20-06-2013

Avoidable costs of more than $200 billion are incurred each year in the US health care system as a result…

Antibiotics and Infectious diseasesDiabetesFinancialGenericsHealthcareNorth AmericaPharmaceutical

Novo Nordisk's Ryzodeg passes regulatory hurdle in Japan; diabetes burden review

03-12-2012

Global insulin market leader Novo Nordisk (NOV: N) of Denmark revealed this morning that its Ryzodeg…

Asia-PacificDegludecDiabetesGlobalHealthcareNovo NordiskPharmaceuticalPricingRegulationRyzodegTresiba

In England, diabetes prescriptions top 40 million, rising 50% in six years

15-08-2012

Diabetes prescriptions in England have for the first time topped the 40 million level in year, a rise…

DiabetesEuropeHealthcarePharmaceuticalPricing

Lack of government funding in Brazil and Mexico holds back use off DPP-IV diabetes drugs

19-07-2012

The majority of type 2 diabetes patients in Brazil and Mexico rely heavily or entirely on government-sponsored…

DiabetesHealthcareMarkets & MarketingPharmaceuticalSouth America

Novo Nordisk links with JDRF on type 1 diabetes R&D; type 2 study results

14-06-2012

Danish insulin giant Novo Nordisk (NOV: N) is partnering with the US charitable organization JDRF to…

DiabetesHealthcareNovo NordiskPharmaceuticalResearch

Focus on the high cost of diabetes at OECD meeting

25-04-2012

Across OECD countries some 83 million people suffer from diabetes and, on current trends, that will rise…

DiabetesHealthcarePharmaceuticalPricing

Women Rxed more medicines than men, but take less, US study finds

19-03-2012

There is a wide gender divide when it comes to how men and women in the USA are prescribed and adhere…

Cardio-vascularDiabetesHealthcareNorth AmericaPharmaceutical

Eli Lilly initiates first international, observational study to understand barriers to progression of insulin treatment

02-12-2011

US drug major Eli Lilly (NYSE: LLY) says it is conducting the first major international, prospective…

DiabetesEli LillyHealthcarePharmaceuticalResearch

Denmark’s Novo Nordisk partners to tackle Qatar’s diabetes problem

24-11-2011

According to Danish insulin giant Novo Nordisk (NVO: N) diabetes is on the rise in Qatar and poses a…

DiabetesHealthcareNovo NordiskPharmaceuticalRest of the World

Diabetes prevalence in urban India soars, with 30% rise in diagnosed population in four years, says GfK HealthCare

20-09-2011

The prevalence of diabetes in urban India is accelerating at a rapid rate and now stands at 5.5% (just…

Asia-PacificDiabetesHealthcareMarkets & MarketingPharmaceutical

Diabetes treatments now 8.4% of UK annual NHS drugs bill, says report

24-08-2011

Diabetes prescriptions now account for 8.4 per of the entire National Health Service net bill for primary…

DiabetesEuropeHealthcareMarkets & MarketingPharmaceuticalPricing

Back to top